(HB-8207) General Information Documentation Print Email Share Share this product Facebook Twitter Google+ U.S. Patent Number 4,504,586 Biosafety Level 1 Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. Comments Animals were immunized with purified CSF-I.Spleen cells were fused with Sp2/0-Ag14 myeloma cells.CSF-I was purified from medium conditioned by MIA PaCa-2 (ATCC CRL-1420). Shipped frozen Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. Permits These permits may be required for shipping this product: Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment. Basic Documentation Product Sheet Certificate of Analysis SDS References Nicolson M. Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1. US Patent 4,504,586 dated Mar 12 1985 . . Hybridoma 2: 137, 1983.